
FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug
The Food and Drug Administration on Wednesday approved Eli Lilly‘s blockbuster drug tirzepatide for weight loss, paving the way for even wider use of